TP53 Intron 6 Polymorphism and Cancer Risk
Author Information
Author(s): D Mavridou, R Gornall, I G Campbell, D M Eccles
Primary Institution: University of Southampton
Hypothesis
Does the TP53 intron 6 polymorphism increase the risk of ovarian and breast cancer?
Conclusion
The study found a significant association between the N' allele of the TP53 intron 6 polymorphism and ovarian cancer, but not with breast cancer.
Supporting Evidence
- The study involved 224 women with ovarian cancer, 224 with breast cancer, and 254 control subjects.
- The N' allele was significantly more prevalent in ovarian cancer patients compared to controls.
- There was no significant difference in the prevalence of the N' allele in breast cancer patients compared to controls.
Takeaway
Scientists looked at a specific change in a gene called TP53 to see if it makes women more likely to get ovarian or breast cancer. They found it might be linked to ovarian cancer but not breast cancer.
Methodology
The frequency of TP53 intron 6 polymorphism alleles was investigated in women with ovarian and breast cancer and compared to control subjects using PCR and sequencing.
Limitations
The findings need to be confirmed in other populations due to previous conflicting reports.
Participant Demographics
All participants were Caucasian women from southern England.
Statistical Information
P-Value
0.01
Statistical Significance
p=0.01
Want to read the original?
Access the complete publication on the publisher's website